Endothelial dysfunction: cardiovascular risk factors, therapy, and outcome

HAR Hadi, CS Carr, J Al Suwaidi - Vascular health and risk …, 2005 - Taylor & Francis
Endothelial dysfunction is a well established response to cardiovascular risk factors and
precedes the development of atherosclerosis. Endothelial dysfunction is involved in lesion …

Endothelial dysfunction in diabetes mellitus

HAR Hadi, JA Suwaidi - Vascular health and risk management, 2007 - Taylor & Francis
Diabetes mellitus is associated with an increased risk of cardiovascular disease, even in the
presence of intensive glycemic control. Substantial clinical and experimental evidence …

Effects of different diets used in diet-induced obesity models on insulin resistance and vascular dysfunction in C57BL/6 mice

P Lang, S Hasselwander, H Li, N Xia - Scientific Reports, 2019 - nature.com
The aim of the present study was to compare different diets used to induce obesity in a head-
to-head manner with a focus on insulin resistance and vascular dysfunction. Male C57BL/6J …

Sleep-disordered breathing and insulin resistance in middle-aged and overweight men

NM Punjabi, JD Sorkin, LI Katzel… - American journal of …, 2002 - atsjournals.org
Sleep-disordered breathing is a prevalent condition associated with impairment of daytime
function and may predispose individuals to metabolic abnormalities independent of obesity …

Diabetes and endothelial dysfunction: a clinical perspective

J Calles-Escandon, M Cipolla - Endocrine reviews, 2001 - academic.oup.com
The main etiology for mortality and a great percent of morbidity in patients with diabetes
mellitus is atherosclerosis. A hypothesis for the initial lesion of atherosclerosis is endothelial …

[HTML][HTML] PAI‐1 and atherothrombosis

DE Vaughan - Journal of Thrombosis and Haemostasis, 2005 - Elsevier
Summary Plasminogen activator inhibitor‐1 (PAI‐1) is the major physiologic inhibitor of
tissue‐type plasminogen activator in plasma, and is elevated in a variety of clinical situations …

[HTML][HTML] Hyperglycemia: a prothrombotic factor?

BA Lemkes, J Hermanides, JH DeVries… - Journal of Thrombosis …, 2010 - Elsevier
Diabetes mellitus is characterized by a high risk of atherothrombotic events. What is more,
venous thrombosis has also been found to occur more frequently in this patient group. This …

Diabetes mellitus as a prothrombotic condition

PJ Grant - Journal of internal medicine, 2007 - Wiley Online Library
Diabetes mellitus (DM) is characterized by fasting hyperglycaemia and a high risk of
atherothrombotic disorders affecting the coronary, cerebral and peripheral arterial trees. The …

The urokinase plasminogen activator system: a target for anti-cancer therapy

S Ulisse, E Baldini, S Sorrenti… - Current cancer drug …, 2009 - ingentaconnect.com
The urokinase plasminogen activator (uPA) system (uPAS) consists of the uPA, its cognate
receptor (uPAR) and two specific inhibitors, the plasminogen activator inhibitor 1 (PAI-1) and …

[HTML][HTML] Plasminogen activator inhibitor-1, inflammation, obesity, insulin resistance and vascular risk

I Juhan-Vague, MC Alessi, A Mavri… - Journal of Thrombosis and …, 2003 - Elsevier
Elevated plasma plasminogen activator inhibitor-1 (PAI-1) level is a core feature of insulin-
resistance syndrome (IRS). Atherothrombotic complications in IRS are partly attributed to …